Chicago Partners Investment Group LLC Sells 1,318 Shares of iShares Biotechnology ETF $IBB

Chicago Partners Investment Group LLC lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 14.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,873 shares of the financial services provider’s stock after selling 1,318 shares during the period. Chicago Partners Investment Group LLC’s holdings in iShares Biotechnology ETF were worth $1,066,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of IBB. Ramirez Asset Management Inc. bought a new stake in iShares Biotechnology ETF in the first quarter worth $26,000. Berkshire Money Management Inc. bought a new stake in iShares Biotechnology ETF in the second quarter worth $28,000. Financial Gravity Asset Management Inc. bought a new stake in iShares Biotechnology ETF in the first quarter worth $30,000. Woodside Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the first quarter worth $31,000. Finally, Harbor Asset Planning Inc. bought a new stake in iShares Biotechnology ETF in the second quarter worth $31,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $156.49 on Tuesday. The company’s fifty day moving average is $143.43 and its 200 day moving average is $131.77. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $157.01.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were paid a dividend of $0.0828 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.